The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
Philip Hammond has dismissed concerns that abolishing stamp duty for first-time buyers will push up house prices.
Elsewhere it will be largely sunny, though with gusty winds at times, and a few showers likely in places.
Heavy rain has caused widespread flooding and travel disruption across north west England and North Wales.